These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7178707)

  • 1. The effector of antibiotics on the Chlamydia family.
    Orfila J; Laurans G
    Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1982; (1):7-82. PubMed ID: 7178707
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
    Wang SA; Papp JR; Stamm WE; Peeling RW; Martin DH; Holmes KK
    J Infect Dis; 2005 Mar; 191(6):917-23. PubMed ID: 15717267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitis.
    Smelov V; Krylova T; Smelova N; Norman L
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S79-82. PubMed ID: 15037332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of an experimental Chlamydia trachomatis salpingitis model for evaluating the effectiveness of antibiotics and anti-inflammatory agents on fertility].
    Verhoest P; Orfila J; Bissac E
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3):309-14. PubMed ID: 9265054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Action of pristinamycin on Chlamydia].
    Orfila J; Haider F
    Pathol Biol (Paris); 1984 May; 32(5):443-5. PubMed ID: 6429616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Miocamycin in chlamydia trachomatis infections in neonatology: clinical results, pharmacokinetics and microbiological evaluation.
    Clerici D; Garlaschi C; Varotto F; Marini A; Scaglione F; Fraschini F
    J Chemother; 1989 Jul; 1(4 Suppl):583-5. PubMed ID: 16312543
    [No Abstract]   [Full Text] [Related]  

  • 7. [Methods of studying the sensitivity of Chlamydia trachomatis to antibiotics].
    Laurans G; Orfila J; Haider F
    Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1982; (2-3):93-106. PubMed ID: 7187965
    [No Abstract]   [Full Text] [Related]  

  • 8. [Advances in the treatment of Chlamydia trachomatis infection].
    Shi LL; Lu JC; Huangfu YM
    Zhonghua Nan Ke Xue; 2005 Apr; 11(4):296-8. PubMed ID: 15921264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of roxithromycin against Chlamydia trachomatis.
    Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
    J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Tryptophan supplementation in the treatment of Chlamydia.
    Singla M
    Med Hypotheses; 2007; 68(2):278-80. PubMed ID: 17045416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative effectiveness of the strategies of etiotropic therapy of generalized chlamydia infections in young patients].
    Pozniak AL; Lobzin IuV; Babkin PA
    Urologiia; 2000; (5):23-6. PubMed ID: 11392219
    [No Abstract]   [Full Text] [Related]  

  • 12. Baicalin suppresses expression of Chlamydia protease-like activity factor in Hep-2 cells infected by Chlamydia trachomatis.
    Hao H; Aixia Y; Dan L; Lei F; Nancai Y; Wen S
    Fitoterapia; 2009 Oct; 80(7):448-52. PubMed ID: 19524644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure.
    Somani J; Bhullar VB; Workowski KA; Farshy CE; Black CM
    J Infect Dis; 2000 Apr; 181(4):1421-7. PubMed ID: 10762573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological study of neonatal conjunctivitis with special reference to Chlamydia trachomatis.
    Mohile M; Deorari AK; Satpathy G; Sharma A; Singh M
    Indian J Ophthalmol; 2002 Dec; 50(4):295-9. PubMed ID: 12532494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diseases from Chlamydia trachomatis].
    Med Monatsschr Pharm; 2001 Aug; 24(8):255-8. PubMed ID: 11515198
    [No Abstract]   [Full Text] [Related]  

  • 16. Azithromycin treatment modulates cytokine production in Chlamydia trachomatis infected women.
    Srivastava P; Jha HC; Salhan S; Mittal A
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):478-82. PubMed ID: 19389045
    [No Abstract]   [Full Text] [Related]  

  • 17. Chlamydia trachomatis infections: therapeutic implications.
    Wesche DL
    P N G Med J; 1989 Mar; 32(1):65-70. PubMed ID: 2750326
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of Chlamydia trachomatis infections.
    Schachter J
    J Chemother; 1989 Jul; 1(4 Suppl):899-901. PubMed ID: 16312695
    [No Abstract]   [Full Text] [Related]  

  • 19. [In vitro and in vivo activity of spiramycine on Chlamydia (author's transl)].
    Orfila J; Haider F; Thomas D
    Pathol Biol (Paris); 1982 Jun; 30(6):449-51. PubMed ID: 7050851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms.
    Smelov V; Perekalina T; Gorelov A; Smelova N; Artemenko N; Norman L
    Eur Urol; 2004 Nov; 46(5):647-50. PubMed ID: 15474277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.